🔗 Share this article

The prestigious award in medical science was awarded for transformative findings that clarify how the immune system attacks dangerous pathogens while protecting the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this honor.

The work identified specialized "security guards" within the immune system that remove rogue defense cells that could harming the organism.

These findings are now enabling new therapies for autoimmune diseases and cancer.

The winners will divide a prize fund worth 11m SEK.

Crucial Discoveries

"Their research has been decisive for comprehending how the immune system operates and the reason we do not all suffer from serious self-attack conditions," commented the head of the Nobel Committee.

This team's research explain a core mystery: In what way does the immune system protect us from numerous infections while keeping our healthy cells unharmed?

Our immune system uses white blood cells that search for signs of disease, including viruses and bacteria it has not met before.

These defenders utilize detectors—known as recognition units—that are produced by chance in countless variations.

This provides the defense network the ability to combat a broad range of invaders, but the randomness of the process inevitably creates white blood cells that may target the body.

Protectors of the Immune System

Researchers earlier knew that a portion of these harmful white blood cells were eliminated in the thymus—where immune cells mature.

This year's Nobel Prize recognizes the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the system to disarm any defenders that assault the healthy cells.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

A prize committee stated, "These discoveries have established a new field of research and spurred the creation of new therapies, for instance for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from fighting the tumor, so research are focused on lowering their numbers.

In self-attack disorders, experiments are testing increasing T-reg cells so the organism is no longer under attack. A comparable method could also be useful in reducing the chances of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting immune cells from healthy animals could stop the disease—suggesting there was a system for preventing defenders from harming the host.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a gene vital for the way regulatory T-cells operate.

"The groundbreaking research has revealed how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the body's own tissues," commented a prominent physiology expert.

"This work is a remarkable example of how basic biological study can have far-reaching implications for human health."